Nicolas Musi,  Assistant Professor; M.D., Universidad Anahuac, Mexico City, 1994.
Telephone: (210) 567-6691 E-mail: musi@uthscsa.edu
 

 

Fernandez M, Triplitt C, Wajcberg E, Sriwijilkamol AA, Musi N, Cusi K, Defronzo R, Cersosimo E.
Addition of Pioglitazone and Ramipril to Intensive Insulin Therapy in Type 2 Diabetic Patients Improves Vascular Dysfunction by Different Mechanisms.
Diabetes Care. 2007 Oct 1; [Epub ahead of print]
PMID: 17909084

Wang L, Balas B, Christ-Roberts CY, Kim RY, Ramos FJ, Kikani CK, Li C, Deng C, Reyna S, Musi N, Dong LQ, DeFronzo RA, Liu F.
Peripheral disruption of the Grb10 gene enhances insulin signaling and sensitivity in vivo.
Mol Cell Biol. 2007 Sep;27(18):6497-505. Epub 2007 Jul 9.
PMID: 17620412

Bajaj M, Suraamornkul S, Hardies LJ, Glass L, Musi N, DeFronzo RA.
Effects of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus.
Diabetologia. 2007 Aug;50(8):1723-31. Epub 2007 May 23.
PMID: 17520238

Laine PS, Schwartz EA, Wang Y, Zhang WY, Karnik SK, Musi N, Reaven PD.
Palmitic acid induces IP-10 expression in human macrophages via NF-kappaB activation.
Biochem Biophys Res Commun. 2007 Jun 22;358(1):150-5. Epub 2007 Apr 20.
PMID: 17467667

Luptak I, Shen M, He H, Hirshman MF, Musi N, Goodyear LJ, Yan J, Wakimoto H, Morita H, Arad M, Seidman CE, Seidman JG, Ingwall JS, Balschi JA, Tian R.
Aberrant activation of AMP-activated protein kinase remodels metabolic network in favor of cardiac glycogen storage.
J Clin Invest. 2007 May;117(5):1432-9. Epub 2007 Apr 12.
PMID: 17431505

Wajcberg E, Sriwijitkamol A, Musi N, DeFronzo RA, Cersosimo E.
Relationship between vascular reactivity and lipids in Mexican-Americans with type 2 diabetes treated with pioglitazone.
J Clin Endocrinol Metab. 2007 Apr;92(4):1256-62. Epub 2007 Jan 23.
PMID: 17244785

Sriwijitkamol A, Coletta DK, Wajcberg E, Balbontin GB, Reyna SM, Barrientes J, Eagan PA, Jenkinson CP, Cersosimo E, DeFronzo RA, Sakamoto K, Musi N.
Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: a time-course and dose-response study.
Diabetes. 2007 Mar;56(3):836-48.
PMID: 17327455

Lee MJ, Feliers D, Mariappan MM, Sataranatarajan K, Mahimainathan L, Musi N, Foretz M, Viollet B, Weinberg JM, Choudhury GG, Kasinath BS.
A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy.
Am J Physiol Renal Physiol. 2007 Feb;292(2):F617-27. Epub 2006 Oct 3.
PMID: 17018841

Schimmack G, Defronzo RA, Musi N.
AMP-activated protein kinase: Role in metabolism and therapeutic implications.
Diabetes Obes Metab. 2006 Nov;8(6):591-602. Review.
PMID: 17026483

Kuhl JE, Ruderman NB, Musi N, Goodyear LJ, Patti ME, Crunkhorn S, Dronamraju D, Thorell A, Nygren J, Ljungkvist O, Degerblad M, Stahle A, Brismar TB, Andersen KL, Saha AK, Efendic S, Bavenholm PN.
Exercise training decreases the concentration of malonyl-CoA and increases the expression and activity of malonyl-CoA decarboxylase in human muscle.
Am J Physiol Endocrinol Metab. 2006 Jun;290(6):E1296-303. Epub 2006 Jan 24.
PMID: 16434556

Sriwijitkamol A, Ivy JL, Christ-Roberts C, DeFronzo RA, Mandarino LJ, Musi N.
LKB1-AMPK signaling in muscle from obese insulin-resistant Zucker rats and effects of training.
Am J Physiol Endocrinol Metab. 2006 May;290(5):E925-32. Epub 2005 Dec 13.
PMID: 16352671

Sriwijitkamol A, Christ-Roberts C, Berria R, Eagan P, Pratipanawatr T, DeFronzo RA, Mandarino LJ, Musi N.
Reduced skeletal muscle inhibitor of kappaB beta content is associated with insulin resistance in subjects with type 2 diabetes: reversal by exercise training.
Diabetes. 2006 Mar;55(3):760-7.
PMID: 16505240

Musi N, Goodyear LJ.
Insulin resistance and improvements in signal transduction.
Endocrine. 2006 Feb;29(1):73-80. Review.
PMID: 16622294

Musi N.
AMP-activated protein kinase and type 2 diabetes.
Curr Med Chem. 2006;13(5):583-9. Review.
PMID: 16515522

Ahmad F, Arad M, Musi N, He H, Wolf C, Branco D, Perez-Atayde AR, Stapleton D, Bali D, Xing Y, Tian R, Goodyear LJ, Berul CI, Ingwall JS, Seidman CE, Seidman JG.
Increased alpha2 subunit-associated AMPK activity and PRKAG2 cardiomyopathy.
Circulation. 2005 Nov 15;112(20):3140-8. Epub 2005 Nov 7.
PMID: 16275868

Musi N, Hirshman MF, Arad M, Xing Y, Fujii N, Pomerleau J, Ahmad F, Berul CI, Seidman JG, Tian R, Goodyear LJ.
Functional role of AMP-activated protein kinase in the heart during exercise.
FEBS Lett. 2005 Apr 11;579(10):2045-50.
PMID: 15811316

Fujii N, Aschenbach WG, Musi N, Hirshman MF, Goodyear LJ.
Regulation of glucose transport by the AMP-activated protein kinase.
Proc Nutr Soc. 2004 May;63(2):205-10. Review.
PMID: 15294031

Musi N, Goodyear LJ.
AMP-activated protein kinase and muscle glucose uptake.
Acta Physiol Scand. 2003 Aug;178(4):337-45. Review.
PMID: 12864738

Xing Y, Musi N, Fujii N, Zou L, Luptak I, Hirshman MF, Goodyear LJ, Tian R.
Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative alpha2 subunit of AMP-activated protein kinase.
J Biol Chem. 2003 Aug 1;278(31):28372-7. Epub 2003 May 23.
PMID: 12766162

Musi N, Yu H, Goodyear LJ.
AMP-activated protein kinase regulation and action in skeletal muscle during exercise.
Biochem Soc Trans. 2003 Feb;31(Pt 1):191-5. Review.
PMID: 12546683

Musi N, Goodyear LJ.
Targeting the AMP-activated protein kinase for the treatment of type 2 diabetes.
Curr Drug Targets Immune Endocr Metabol Disord. 2002 Jul;2(2):119-27. Review.
PMID: 12476786

Musi N, Hirshman MF, Nygren J, Svanfeldt M, Bavenholm P, Rooyackers O, Zhou G, Williamson JM, Ljunqvist O, Efendic S, Moller DE, Thorell A, Goodyear LJ.
Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes.
Diabetes. 2002 Jul;51(7):2074-81.
PMID: 12086935

Tian R, Musi N, D'Agostino J, Hirshman MF, Goodyear LJ.
Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy.
Circulation. 2001 Oct 2;104(14):1664-9.
PMID: 11581146

Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE.
Role of AMP-activated protein kinase in mechanism of metformin action.
J Clin Invest. 2001 Oct;108(8):1167-74.
PMID: 11602624

Musi N, Hayashi T, Fujii N, Hirshman MF, Witters LA, Goodyear LJ.
AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle.
Am J Physiol Endocrinol Metab. 2001 May;280(5):E677-84.
PMID: 11287349

Musi N, Fujii N, Hirshman MF, Ekberg I, Froberg S, Ljungqvist O, Thorell A, Goodyear LJ.
AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise.
Diabetes. 2001 May;50(5):921-7.
PMID: 11334434

Musi N, Braverman LE, Norris CM Jr.
Severe thyrotoxicosis after parathyroid surgery for hyperparathyroidism.
Am J Med. 2000 Apr 15;108(6):519-20. No abstract available.
PMID: 10866589